The Urolume as a means of treating XXXX and its impact on waiting lists.

@entity1 @entity3833 @entity322 @entity3585
OBJECTIVE: To evaluate the effectiveness of the prostatic stenting device--the Urolume--both in terms of relief from @entity3585 and as a means of reducing waiting lists. @entity1 AND METHODS: A group of 70 @entity1 from the long-term waiting list were chosen for this study. The Urolume, a mesh tube of biomedical superalloy, was successfully introduced in 60 of these @entity1 . The majority had the procedure performed as a day case, under a general anaesthetic. RESULTS: Seventy-two per cent of @entity1 were symptomatically better when assessed at 6 weeks and their mean peak urinary flow rates had doubled. Early problems included haematuria, urge @entity322 and @entity3833 . Stent displacement necessitating removal occurred in 10 @entity1 . CONCLUSION: This technique offers the surgeon a quick and atraumatic method of relieving @entity3585 . There are, however, a number of problems associated with this technique which will probably be overcome by modification to the Urolume. As a result of our project, the waiting time for prostatic surgery was reduced from 3 years to under 2 years.
